Skip to main content
. 2024 Feb 7;165(7):1613–1624. doi: 10.1097/j.pain.0000000000003168

Table 2.

Patients' characteristics.

CRPS (n = 20) Healthy controls (n = 20)
Age [y] (mean ± SD (range)) 49 ± 12 (26-70) 51 ± 12 (22-71)
Gender (female %) 16 (80%) 17 (85%)
BMI [kg/m2] (mean ± SD) 27.5 ± 5.6 25.0 ± 4.8
CRPS type
 Type I 11 (55%)
 Type II 9 (45%)
CRPS initial phenotype
 Warm 10 (50%)
 Cold 5 (25%)
 Unclear 5 (25%)
Disease duration [mo] (mean ± SD (range))
 Since diagnosis 3.4 ± 4.7
 Since trauma 6.9 ± 5.9
Pain (NRS: numerical rating scale (1-10))
 Mean (mean ± SD) 5.4 ± 1.2
 Max (mean ± SD) 7.8 ± 1.3
 CSS* (mean ± SD) 11.1 ± 2.4
Symptoms
 Edema 15 (75%)
 Allodynia 10 (50%)
Questionnaires
 GCPS (mean ± SD) 1.5 ± 1.1 0.1 ± 0.2
 NPSI (mean ± SD) 38.5 ± 16.1
 BDI II§ (mean ± SD) 16 ± 9.7 4.2 ± 4.0
 STAI-T (mean ± SD) 44.2 ± 5.9 42.1 ± 3.2
*

CRPS severity score, range 0 to 17.

Graded chronic pain scale—disability scores, range 0 to 100.

Neuropathic pain symptom inventory, range 0 to 100.

§

Beck depression inventory II, range 0 to 63.

State-trait anxiety inventory trait anxiety subscale, range 20 to 80.

BMI, body mass index; CRPS, complex regional pain syndrome.